OCT2, the new OCT platform developed by Heidelberg Engineering, was put into use at the International Space Base. Spectralis (Heidelberg Engineering), the first OCT device to go to space, has achieved a new first. OCT 2 Module Spectralis was delivered to the International Space Base and started to be used from astronauts. The new module can scan much faster and take images with higher resolution than the Specratlis OCT, which was sent to the International Space Base in 2013. This project is of great importance in terms of showing the changes that can occur in the human eye in low gravity condition.
New OCT2 platform started to be used at the International Space Base
Previous articleScientific studies on self-examination with the home OCT started
Next articleVirtual Imaging Symposium
OTHER ARTICLES
Transcorneal Electrical Stimulation Therapy May Have a...
Dizdar Yigit and co-workers aimed to assesses the effects of transcorneal electrical stimulation on several objective and subjective measures of visual function in retinitis...
No difference in the incidence of age-related...
Age-related macular degeneration shares many of the same risk factors with atherosclerosis. There is a postulated role of lipid-lowering agents in preventing age-related macular...
Subjects with central serous chorioretinopathy are at...
Lee and co-workers aimed to estimate the risk of incident age-related macular degeneration (AMD) in patients with central serous chorioretinopathy (CSC). During a recent...
Retinal age as a predictive biomarker for...
Zhu and co-workers aimed to develop a deep learning (DL) model that predicts age from fundus images (retinal age) and to investigate the association...
